Boai NKY Pharmaceuticals Ltd Net Asset Quality Index
Boai NKY Pharmaceuticals Ltd net asset quality index. Boai NKY Pharmaceuticals Ltd (300109) has a Net Asset Quality Index of 77.5% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥4.28 Billion minus total liabilities of CN¥961.75 Million yields net assets of CN¥3.32 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See 300109 net assets for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Boai NKY Pharmaceuticals Ltd (2007–2025)
Net asset quality index of Boai NKY Pharmaceuticals Ltd from 2007 to 2025. This chart shows how Boai NKY Pharmaceuticals Ltd's Net Asset Quality Index has evolved across 19 annual periods from 2007 to 2025. As of June 2026, the index stands at 77.5%, representing net assets of CN¥3.32 Billion against total assets of CN¥4.28 Billion CNY. Check 300109 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Boai NKY Pharmaceuticals Ltd Net Asset Quality Index by Year (2007–2025)
Boai NKY Pharmaceuticals Ltd net asset quality index by year from 2007 to 2025. The table below presents the year-by-year Net Asset Quality Index for Boai NKY Pharmaceuticals Ltd from 2007 to 2025, covering 19 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 300109 company net worth.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 83.7% | CN¥3.66 Billion | CN¥4.37 Billion | CN¥713.16 Million | ▲ +1.2 pp |
| 2024 | 82.5% | CN¥3.61 Billion | CN¥4.37 Billion | CN¥764.37 Million | ▼ -5.1 pp |
| 2023 | 87.6% | CN¥3.52 Billion | CN¥4.02 Billion | CN¥499.66 Million | ▲ +3.6 pp |
| 2022 | 83.9% | CN¥3.12 Billion | CN¥3.71 Billion | CN¥596.29 Million | ▼ -1.3 pp |
| 2021 | 85.2% | CN¥3.40 Billion | CN¥3.99 Billion | CN¥589.76 Million | ▲ +11.0 pp |
| 2020 | 74.2% | CN¥3.08 Billion | CN¥4.15 Billion | CN¥1.07 Billion | ▲ +1.5 pp |
| 2019 | 72.7% | CN¥3.05 Billion | CN¥4.20 Billion | CN¥1.14 Billion | ▲ +17.3 pp |
| 2018 | 55.4% | CN¥1.28 Billion | CN¥2.30 Billion | CN¥1.03 Billion | ▼ -11.1 pp |
| 2017 | 66.5% | CN¥1.30 Billion | CN¥1.96 Billion | CN¥656.22 Million | ▼ -27.1 pp |
| 2016 | 93.6% | CN¥1.23 Billion | CN¥1.31 Billion | CN¥83.32 Million | ▼ -0.4 pp |
| 2015 | 94.1% | CN¥1.16 Billion | CN¥1.24 Billion | CN¥73.11 Million | ▲ +9.8 pp |
| 2014 | 84.3% | CN¥400.25 Million | CN¥474.63 Million | CN¥74.38 Million | ▼ -4.9 pp |
| 2013 | 89.2% | CN¥377.06 Million | CN¥422.64 Million | CN¥45.58 Million | ▲ +0.4 pp |
| 2012 | 88.8% | CN¥363.81 Million | CN¥409.62 Million | CN¥45.81 Million | ▼ -1.2 pp |
| 2011 | 90.0% | CN¥350.93 Million | CN¥389.74 Million | CN¥38.80 Million | ▼ -3.1 pp |
| 2010 | 93.1% | CN¥333.21 Million | CN¥357.81 Million | CN¥24.60 Million | ▲ +37.0 pp |
| 2009 | 56.1% | CN¥62.14 Million | CN¥110.80 Million | CN¥48.66 Million | ▲ +8.0 pp |
| 2008 | 48.0% | CN¥43.93 Million | CN¥91.45 Million | CN¥47.52 Million | ▲ +21.3 pp |
| 2007 | 26.7% | CN¥17.82 Million | CN¥66.66 Million | CN¥48.84 Million | — |